Cheil Bio Co

Cheil Bio Co Interest Expense

Delisted·Feb 25, 2026

The Interest Expense of Cheil Bio Co (052670.KQ) as of Nov 17, 2026 is 479.01 M KRW. In the previous year, Interest Expense was 765.33 M KRW — a change of -37.41% (lower).

Interest Expense

479.01 MKRW

YoY

-37.41%

Last updated:

Interest Expense of Cheil Bio Co is 2024 479.01 M KRW. Interest Expense of Cheil Bio Co was 2023 765.33 M KRW. It decreases by -37.41% lower compared to the previous year.

The Cheil Bio Co Interest Expense history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Interest Expense
Date
Interest Expense
Jan 1, 2017
376.00 M KRW
Jan 1, 2018
40.00 M KRW
Jan 1, 2019
2.07 B KRW
Jan 1, 2020
1.66 B KRW
Jan 1, 2021
1.80 B KRW
Jan 1, 2022
-250.80 M KRW
Jan 1, 2023
765.33 M KRW
Jan 1, 2024
479.01 M KRW
The Cheil Bio Co Interest Expense history
YEARInterest ExpenseYoY
479.01 MKRW-37.41%
765.33 MKRW-405.15%
-250.80 MKRW-113.95%
1.80 BKRW+8.40%
1.66 BKRW-19.89%
2.07 BKRW+5,077.50%
40.00 MKRW-89.36%
376.00 MKRW+4.74%
359.00 MKRW+529.82%
57.00 MKRW-812.50%
-8.00 MKRW—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cheil Bio Co Stock analysis

What does Cheil Bio Co do? Cheil Bio Co., Ltd. generates revenue through the production and sale of veterinary products for pigs, cattle, chickens, cows, and aquatic animals. The company offers antibiotics, antimicrobials, lactobacillus, enzyme preparations, parasiticides, antiseptics, organic trace minerals, vaccines, and diagnostic kits including ELISA test kits, virus test kits, and DNA kits. These products are primarily sold to the domestic market, targeting livestock farmers and veterinary clinics. The firm also provides feed additives as part of its product portfolio. The company's product range includes specialized solutions for cattle, pigs, chickens, pets, and other animals, with a focus on health management and disease prevention. Veterinary clinics and livestock farms form the core customer segments, purchasing antibiotics, vaccines, and diagnostic tools to maintain animal health. The domestic market remains the primary sales channel, with no mention of international distribution. Cheil Bio's offerings are designed to address common health challenges in livestock, such as infections and parasitic infestations, through both preventive and therapeutic products. The inclusion of diagnostic kits like ELISA and DNA tests supports advanced veterinary care, enhancing the company's value proposition for professional animal health providers. Cheil Bio Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Cheil Bio Co stock

Interest Expense of Cheil Bio Co is 479.01 M KRW in 2024.

Interest Expense of Cheil Bio Co changed from 765.33 M KRW to 479.01 M KRW, representing a -37.41% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Interest Expense Cheil Bio Co since 2006 – with annual values, charts, and detailed analysis.

Interest expense represents the cost of borrowing. Higher interest expenses can indicate a highly leveraged company.

Interest Expense's KRW is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Interest Expense's Cheil Bio Co historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — Cheil Bio Co

All Key Metrics — Cheil Bio Co